<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>60(8)</volume><submitter>Rohrig W</submitter><funding>Friedrich-Alexander-Universität Erlangen-Nürnberg</funding><pubmed_abstract>Endocannabinoids and endocannabinoid-related compounds (ERCs) are involved in many physiological processes. They are released on demand from phosphoinositide and &lt;i>N&lt;/i>-acylphosphatidyl ethanolamine (NAPE) precursors and comprise 2-monoacylglycerols (2-MGs) and FA ethanolamides (FEAs). Despite the abundance of advanced quantitative methods, however, their determined concentrations in blood plasma are inconsistent because 2-MGs and FEAs undergo artifactual de novo formation, chemical isomerization, and degradation during sample collection and storage. For a comprehensive survey of these compounds in blood and plasma, we have developed and validated an ultra-HPLC-MS/MS method to quantify 24 endocannabinoids, ERCs, and their phospholipid precursors. Immediate acidification of EDTA-blood to </pubmed_abstract><journal>Journal of lipid research</journal><pagination>1475-1488</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6672038</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS.</pubmed_title><pmcid>PMC6672038</pmcid><pubmed_authors>Deutsch B</pubmed_authors><pubmed_authors>Rohrig W</pubmed_authors><pubmed_authors>Achenbach S</pubmed_authors><pubmed_authors>Pischetsrieder M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS.</name><description>Endocannabinoids and endocannabinoid-related compounds (ERCs) are involved in many physiological processes. They are released on demand from phosphoinositide and &lt;i>N&lt;/i>-acylphosphatidyl ethanolamine (NAPE) precursors and comprise 2-monoacylglycerols (2-MGs) and FA ethanolamides (FEAs). Despite the abundance of advanced quantitative methods, however, their determined concentrations in blood plasma are inconsistent because 2-MGs and FEAs undergo artifactual de novo formation, chemical isomerization, and degradation during sample collection and storage. For a comprehensive survey of these compounds in blood and plasma, we have developed and validated an ultra-HPLC-MS/MS method to quantify 24 endocannabinoids, ERCs, and their phospholipid precursors. Immediate acidification of EDTA-blood to </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Aug</publication><modification>2025-04-04T23:21:52.181Z</modification><creation>2025-04-04T23:21:52.181Z</creation></dates><accession>S-EPMC6672038</accession><cross_references><pubmed>31235475</pubmed><doi>10.1194/jlr.d094680</doi><doi>10.1194/jlr.D094680</doi></cross_references></HashMap>